ARCHIVES

Biological Modifiers Journal Objects To NEJ Policy, Says It Will OK Clinical Data Release

This article is from The Cancer Letter archive.

Vol. 11 No. 17 | April 26, 1985

Download PDF Visit The Full Archive

Related Articles

ASCO TO NCI: Review Auditing Procedures, Re-Establish Trust

May 27, 1994

U. S. Oncologists To Audit Another Bezwoda Trial.

November 10, 2000

In Congress: Tamoxifen Results Well Communicated, Understood, NCI Says

May 1, 1998

PRI’s Frederick Fee $903,866 For First Six Months Of New Contract

September 2, 1988

In Brief: Masnyk Named DCBD Deputy Director Maizel to Head NCI’s “Supercomputer” Development

November 2, 1984

In Brief: NIH Funding For Shannon Awards To Fall, Eight Institutes Decide Not To Participate

August 13, 1993